HERTRAZ TRASTUZUMAB INJECTION

Get a Price/Quote

MOQ : 1 Bottle

HERTRAZ TRASTUZUMAB INJECTION Specification

Salt Composition
Trastuzumab

Pacakaging (Quantity Per Box)
1 Vial per box

Dosage Form
Lyophilized Powder for Solution for Injection

Indication
HER2 Positive Breast and Gastric Cancer

Origin of Medicine
Biological

Drug Type
Prescription

Ingredients
Trastuzumab

Physical Form
Injection

Function
Anti-cancer, HER2 receptor antagonist

Recommended For
Breast Cancer, Metastatic Gastric Cancer

Dosage
As directed by physician

Dosage Guidelines
Administered by healthcare professionals

Suitable For
Adults

Quantity
440 mg per vial

Storage Instructions
Store in a refrigerator (2C - 8C), Do not freeze

HERTRAZ TRASTUZUMAB INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About HERTRAZ TRASTUZUMAB INJECTION

PRODUCT DETAILS

Brand Name: HERTRAZ
Content: Trastuzumab
Strengths: 440 Mg & 150 mg
Form: VIAL
Packing: single dose vial
Manufactured By: Mylan

Note :- HERTRAZ Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Precision Treatment for HER2-Positive Cancers

HERTRAZ Trastuzumab Injection targets HER2 receptors, effectively limiting the growth and spread of certain breast and gastric cancers. As a targeted therapy, it is typically administered to adult patients identified with HER2-positive tumors, supporting improved treatment outcomes when used as directed by a physician.

Expert Supervision & Hospital Use Only

This medication is strictly administered by healthcare professionals in a hospital setting to ensure safe and effective reconstitution, dosage calculation, and monitoring of potential side effects. Patients should never self-administer HERTRAZ, and usage must be as per the oncologists direction.

Reconstitution and Storage Guidelines

HERTRAZ comes in a lyophilized form and requires reconstitution with the provided diluent before intravenous administration. It must be kept refrigerated (2C - 8C) and should not be frozen. These storage and preparation requirements help preserve the products potency and safety for patient use.

FAQs of HERTRAZ TRASTUZUMAB INJECTION:

Q: How is HERTRAZ Trastuzumab Injection prepared and administered?

A: HERTRAZ is supplied as a lyophilized powder and must be reconstituted with the supplied bacteriostatic or sterile water for injection. After preparation, it is administered as an intravenous infusion by a qualified healthcare professional in a hospital, following the prescribed dosage and infusion duration determined by an oncologist.

Q: What conditions is HERTRAZ recommended for?

A: HERTRAZ is indicated for adults with HER2-positive breast cancer and HER2-positive metastatic gastric cancer. This monoclonal antibody therapy is effective for targeted cancer treatment in patients whose tumors overexpress the HER2 receptor.

Q: When should HERTRAZ not be used?

A: HERTRAZ is contraindicated in individuals who have known hypersensitivity to trastuzumab or any of the excipients present in the formulation. It should also not be used outside of a hospital environment or without the supervision of an oncology specialist.

Q: Where should HERTRAZ be stored after purchase?

A: HERTRAZ vials should be stored in a refrigerator at a temperature between 2C and 8C. It is important not to freeze the vials. Proper storage conditions maintain the integrity and efficacy of the medication until it is ready for reconstitution and administration.

Q: What are the benefits of using HERTRAZ for cancer treatment?

A: HERTRAZ offers targeted inhibition of HER2 receptors, which are associated with aggressive tumor growth in certain breast and gastric cancers. Its precise mechanism helps slow tumor progression and may improve survival rates when integrated into a comprehensive cancer treatment plan.

Q: Is HERTRAZ supplied with a diluent for reconstitution?

A: Yes, the product packaging includes an appropriate diluent (bacteriostatic or sterile water for injection) for reconstituting the lyophilized powder prior to intravenous administration by a healthcare provider.

Q: Who should supervise the administration of HERTRAZ?

A: Only healthcare professionals, specifically those with oncology expertise, should prepare and administer HERTRAZ in a controlled hospital environment to ensure patient safety and optimal treatment efficacy.

Tell us about your requirement